Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/46889
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPathman L.-
dc.contributor.authorBennett M.-
dc.contributor.authord'Udekem Y.-
dc.contributor.authorPhillips R.-
dc.date.accessioned2022-04-04T06:11:12Z-
dc.date.available2022-04-04T06:11:12Z-
dc.date.issued2022-03-04en
dc.identifier.citationAustralasian Journal of Dermatology. 63(1) (pp e60-e62), 2022. Date of Publication: February 2022.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/46889-
dc.description.abstractChildren with erythropoietic porphyria are generally under the care of paediatric dermatologists. When these children undergo major surgery, they are at risk of unusual complications due to their photosensitivity. Dermatologists may be consulted prior to surgery for advice. We describe a case of a child with erythropoietic porphyria undergoing open heart surgery, utilising an exchange transfusion alongside other strategies to minimise the risk of photosensitivity-induced haemolysis.Copyright © 2021 Australasian College of Dermatologists.-
dc.publisherJohn Wiley and Sons Inc-
dc.relation.ispartofAustralasian Journal of Dermatology-
dc.subject.meshallele-
dc.subject.meshanesthesia-
dc.subject.meshcardiopulmonary bypass-
dc.subject.meshclinical clinical decision making-
dc.subject.meshconsultation-
dc.subject.meshelective surgery-
dc.subject.mesherythema-
dc.subject.mesherythropoietic protoporphyria/di erythropoietic protoporphyria/th [Therapy]-
dc.subject.meshexchange blood transfusion-
dc.subject.meshgene mutation-
dc.subject.meshheart surgery-
dc.subject.meshheart ventricle septum defect/su [Surgery]-
dc.subject.meshhospital admission-
dc.subject.meshhospital discharge-
dc.subject.meshintensive care-
dc.subject.meshnear infrared spectroscopy-
dc.subject.meshopen surgery-
dc.subject.meshpediatrics-
dc.subject.meshphotosensitivity-
dc.subject.meshpostoperative period-
dc.subject.meshsun exposure-
dc.subject.meshswelling-
dc.subject.meshdexmedetomidine/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshfentanyl/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshpancuronium/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshsevoflurane/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshtranexamic acid/pv [Special Situation for Pharmacovigilance]-
dc.titleCardiopulmonary bypass in a child with erythropoietic protoporphyria.-
dc.typeArticle-
dc.type.studyortrialCase series or case report-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1111/ajd.13751-
dc.publisher.placeAustralia-
dc.identifier.pubmedid34817070 [https://www.ncbi.nlm.nih.gov/pubmed/?term=34817070]-
dc.identifier.institution(Pathman, Bennett, d'Udekem, Phillips) The Royal Children's Hospital, Melbourne, Australia-
dc.identifier.institution(d'Udekem) Children's National Hospital, Washington, DC, United States-
dc.identifier.institution(Phillips) Monash Medical Centre, Melbourne, Australia-
dc.identifier.institution(Phillips) Murdoch Children's Research Institute, Melbourne, Australia-
dc.identifier.affiliationmh(Phillips) Monash Medical Centre, Melbourne, Australia-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeArticle-
item.cerifentitytypePublications-
Appears in Collections:Articles
Show simple item record

Page view(s)

16
checked on Nov 24, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.